Going Rogue: The Big Tech-Driven Evolution of Acoustic Neuroma Management (AMW)
2021 AAO-HNSF Annual Meeting & OTO Experience
As our society traverses the 21st century, the influence of technology on all phases of life has been profound. However, the complexity and rapidity of technological evolution may at times become burdensome, especially in the practice of medicine. Of the recent big-technology advances, perhaps none has been more impactful than the proliferation of online medical information and the influence of social media platforms. This panel will seek to explore the impact of these technologies specifically as they pertain to the management of patients with vestibular schwannomas. In the first part of the presentation, the panel will review current paradigms for managing vestibular schwannomas. Discussion will include advances in imaging technology, the impact of earlier diagnoses, refinements in operative technology, the influence of stereotactic radiation therapy, and the growing trend toward observation. The second portion of the presentation will address challenges emerging in acoustic neuroma management related to influences of the Big-Tech era. Topics of focus will include the quality and influence of online medical information, management of the self-informed patient, and the effect of regional search engine optimization and social media on referral patterns, patient decision making, and treatment selection. The panel is comprised of Neurotologists hailing from geographically diverse regions of North America and of varying career stage and generational influence. Otolaryngologists and other providers attending this session will receive a succinct review of contemporary standards in vestibular schwannoma management while engaging the panel on how technology is actively changing the face of patient care in skull base surgery. Focus will be given to helping General Otolaryngologists optimize early-phase care delivery to this population while highlighting unique challenges that are emerging in the treatment of younger generations of patients.
Credits
CME:1.0, MOC:1.0